Tagged: FBI

Yes Bob… This Shit Really Does Just Write Itself..

Unsurprising to see the revolving door swing so wide, and how blatantly, however it’s a disturbing development nonetheless..




Wednesday, June 07, 2017

Trump Nominates King & Spalding Attorney


Who is Christopher A. Wray?

Well, he’s a litigation partner in King & Spalding’s Washington DC and Atlanta office.

And who, I hear you ask, are King & Spalding?

Well, they’re the law firm who just got spanked in Chicago. They defended GlaxoSmithKline, arguing that their antidepressant, Paxil, did not cause the suicide of Stewart Dolin.

The jury saw through the weak defence and found Glaxo liable.

Prior to joining the firm, Wray served from 2003 to 2005 as the Assistant Attorney General in charge of the U.S. Department of Justice’s (DOJ) Criminal Division, the same department who, in 2012, slammed down a $3 billion fine after GlaxoSmithKline pleaded guilty to a whole host of federal crimes.

So, what duties does one who becomes director at the FBI have to carry out?

Well, he’s basically responsible for its day-to-day operations.

The FBI has jurisdiction over violations of more than 200 categories of federal crimes.

So nice to know that one of King & Spalding’s biggest and wealthiest clients, GlaxoSmithKline, may now have someone to oversee any future criminal behaviour of theirs.

This shit just writes itself.

Nice move, Don.

Bob Fiddaman


What Became Of The FBI’s Investigation Of GSK In Poland?


The FBI will assist Poland’s Central Anticorruption Office (CBA) in the case of UK pharmaceuticals company GlaxoSmithKline, which is suspected of bribing Polish doctors, the Polish business daily Puls Biznesu wrote April 16.

“The GKS corruption case, which has been under investigation by the CBA and Lodz prosecutor’s office since 2012 and currently includes 13 suspects, will receive assistance from the FBI,” said Pawel Wojtunik, head of the CBA.

US regulations oblige the Securities and Exchange Commission (SEC) to initiate proceedings when suspicions of corruption arise at companies listed on US stock exchanges. This may play an important role as the case develops, especially if GSK were found to have breached the Foreign and Corrupt Practices Act (FCPA).

As reported by CEE Inisght, GSK sales reps had offered bribes to doctors from Lodz in return for prescriptions for GSK drugs between 2010 and 2012.

Jailed Hacker Blames Profanity Laced Youtube Videos On Paxil Withdrawal (Jan 22, 2005)

I have been alerted to a very interesting story about a hacker who was jailed for making threats on youtube against FBI agents who were investigating him. In the court proceedings in this case the accused blamed his out of character- behavior on Paxil withdrawal. This case doesn’t surprise me, in fact it makes perfect sense to me, as I have experienced similar effects from Paxil (Seroxat) as have many others. Paxil can cause all sorts of personality problems, it can literally change your whole character, and in withdrawal you basically go clinically insane in various ways, including mania, depression, anxiety, de-personalization, de-realization, akathisia, aggression etc. In other words you go completely crazy, mad -out of your mind- bonkers. Imagine nicotine withdrawal by a million times the intensity and you might come close to getting how utterly torturous this feels, then imagine that going on for months on end… I don’t know the full details of this case, but I feel for anyone who experienced these horrible Paxil effects, and when this kind of trouble is the result, it makes it all the more tragic….

Hacktivist Barrett Brown Sentenced to Five Years


DALLAS (CN) – Anonymous-linked hacktivist/journalist Barrett Brown was sentenced Thursday to five years in federal prison after pleading guilty to three charges accusing him of posting a hyperlink to stolen credit card information and interfering with execution of search warrants.
At sentencing, U.S. District Judge Sam Lindsay said Brown’s posting of the link “is more than that appears,” citing testimony and documents showing that Brown was an active participant rather than just a mere observer.
“In my mind, it is more than just posting the link,” Lindsay said at the sentencing hearing. “What took place will not chill the First Amendment rights of journalists.”
In his plea agreement, Brown, 33, of Dallas, admitted he hid his computers during execution of a search warrant at his mother’s home, and posted profanity-laced videos of himself threatening to shoot FBI agents investigating him, including Special Agent Robert Smith.
Brown was indicted in October 2012 on charges of making an Internet threat, conspiring to make restricted personal information of a federal employee publicly available, and retaliating against a federal law enforcement officer.
He was indicted a second time and accused of linking to stolen credit card information obtained from Anonymous’ 2011 hacking of Austin-based security firm Stratfor Global Intelligence. Prosecutors claimed the link led to 5,000 credit card account numbers.
A third indictment alleged obstruction of justice for the FBI raid on his mother’s home.
Brown was angry that agents confiscated his computers and questioned his mother, who was later sentenced to one year of probation for obstructing a search warrant. Brown agreed to plead guilty to one charge from each indictment, ending the criminal case against him. He said he had rejected an offer of pleading guilty to one fraud charge even if it meant a lighter sentence.
Judge Lindsay was not persuaded by pleas for leniency by Barrett’s attorneys, who said Brown should be sentenced to 30 months in federal prison and be released immediately with time served.
Lindsay agreed with prosecutors and sentenced Brown to 63 months in federal prison, the maximum allowed under federal sentencing guidelines.
Lindsay also ordered Brown to pay $900,000 in restitution and fines and to serve two years of supervised release.
Defense attorney Charles Swift, with Swift McDonald in Seattle, asked Lindsay to put Brown’s threats against the FBI agents in the context of the “unique world of the Internet.”
Citing this week’s “Deflategate” controversy involving the New England Patriots football team, Swift said the comments people posted with news stories about the controversy as being “over the top” and not the kind of comments people “would make in a public square.”
Linsday was not swayed, pointing to Brown’s hiding his computers and the investigation against his mother as reasons why Brown would be upset.
“I don’t know if your analogy is on point,” Lindsay said. “We have threats being made here during a federal investigation.”
     But Swift urged for a lighter sentence, saying that Brown’s “uncharacteristic rage and mental state” at the time was the result of a drug dependency that he was trying to break.
“Brown has used narcotics from an early age and his personality changed when he tried to go off” them, Swift said.
Lindsay was not persuaded, citing the threats made against Smith and his children.
“As a public official, I have no way of assessing his mental state if he makes threats against me,” Lindsay said.
The judge added that if allowed to stand, the threats would have a chilling effect on federal officials who were doing their jobs.
Lindsay cited several letters in support of Brown by other journalists and members of the public. He also listened to a statement by D Magazine editor Tim Rogers on Brown’s behalf, who told the judge that Brown had been writing for his publication while in jail and that he would hire him if he were released.
Speaking on his own behalf, Brown expressed his regret for “some of the things I have done.”
     He blamed his “manic state” in the videos on “sudden withdrawal from Paxil and Suboxone.”
“I don’t think anyone doubts that I regret quite a bit about my life, including some of the things that brought me here today,” Brown said. “Your Honor has the acceptance of responsibility document that my counsel submitted to you. Every word of it was sincere.”
Brown denied being the spokesman for Anonymous, but acknowledged his ties to the hacktivist group.
Brown acknowledged that he “didn’t have the right” to hide his computer files from federal agents, and said he would have been better off trying to protect contributors to his ProjectPM “think tank” by going through the courts.
Brown also thanked Lindsay for overruling an earlier request by prosecutors to subpoena information about those contributors.
“I do not want to be a hypocrite,” Brown said. “If I criticize the government for breaking the law but then break the law myself in an effort to reveal their wrongdoing, I should expect to be punished, just as I have called for the criminals at government-linked firms like HBGary and Palantir to be punished.”
Immediately after sentencing, Brown released a statement mocking federal officials for prosecuting his case.
“The U.S. government decided today that because I did such a good job investigating the cyber-industrial complex, they’re now going to send me to investigate the prison-industrial complex,” Brown said.
“For the next 35 months, I’ll be provided with free food, clothes, and housing as I seek to expose wrongdoing by Bureau of Prisons officials and staff and otherwise report on news and culture in the world’s greatest prison system. I want to thank the Department of Justice for having put so much time and energy into advocating on my behalf; rather than holding a grudge against me for the two years of work I put into in bringing attention to a DOJ-linked campaign to harass and discredit journalists like Glenn Greenwald, the agency instead labored tirelessly to ensure that I received this very prestigious assignment.”

FBI Interviews Glaxo Employees


Federal Bureau of Investigation agents have been interviewing current and formerGlaxoSmithKline GSK.LN -3.16% PLC employees in connection with bribery allegations made against the drug maker in China, according to a person familiar with the matter, as fresh claims of corruption surfaced against Glaxo’s operations in Syria.

The interviews have taken place in Washington, D.C., in the past few months and are part of a Justice Department investigation into Glaxo’s activities in China, the person added.

The U.S. Securities and Exchange Commission also is investigating the company’s business in China, according to people familiar with the matter. Spokeswomen for the SEC and FBI separately declined to comment.

Chinese authorities have accused Glaxo’s former top executive in that country, U.K. national Mark Reilly, of “large-scale” bribery. Mr. Reilly couldn’t be reached for comment and hasn’t commented in the past.

Glaxo said it is cooperating with the Chinese authorities, and has informed the Justice Department and the SEC of the Chinese investigation. A spokesman for the company declined to comment on the FBI interviews and said Glaxo’s discussions with regulators were confidential.

The U.K.’s Serious Fraud Office also is investigating Glaxo for possible criminal violations in its commercial practices, the company said in May.

Last week, Glaxo received an anonymous email claiming its employees in Syria bribed doctors and pharmacists over the past five years to promote products including painkiller Panadol and toothpaste Sensodyne.

The bribes took the form of cash payments, speaking fees, trips, free dinners and free samples, said the email, which was reviewed by The Wall Street Journal. The email cited names and dates.

Doctors promoting Glaxo’s cold and flu products were paid $2,500 in cash in December 2010, the email says, while $2,500 was paid to a national dental association in return for getting Glaxo’s Sensodyne logo on dentists’ prescription notepads.

Syrian health officials allegedly received bribes from Glaxo employees to fast-track registration of its Sensodyne dental products, including cash payments and a trip to a 2011 conference in Rome, the email maintains.

Glaxo employees also were involved in smuggling a narcotic product from Syria into Iran, the email alleges.

The product in question, pseudoephedrine, is a raw ingredient of Glaxo’s congestion medicine Actifed and can also be used in the production of methamphetamine. The Syria allegations was reported by Reuters on Thursday.

Glaxo’s consumer-health operations in Syria—where the bribery allegations are being made—were closed in 2012 as the country’s civil war worsened. Glaxo retains its prescription-medicine operations in Syria.

Glaxo said it would thoroughly investigate all claims made in the Syria email, and said it has asked the sender for more information. The company said it has zero tolerance for unethical behavior, adding, “We welcome people speaking up if they have concerns about alleged misconduct.”

The SEC has recently started giving whistleblowers a cut of any settlement reached as the result of allegations detailing securities-law violations—providing a financial incentive for anyone with concerns to step forward.

Under the U.S. Foreign Corrupt Practices Act, which falls under the SEC whistleblower program, it is illegal for companies with significant U.S. operations to bribe foreign officials in exchange for business. In 2010 Glaxo disclosed it had been contacted by the Justice Department and the SEC about its overseas operations as part of a wider FCPA investigation into pharmaceutical-industry business practices abroad, including in China. The agencies also began investigating the more recent allegations in China last year, according to people familiar with the matter.

The Syria email follows allegations of bribes paid by Glaxo employees in China, Iraq,Jordan, Lebanon and Poland in the past 12 months.

The tens of thousands of dollars in bribes allegedly paid in Syria are on a much smaller scale than the allegations in China, where officials last July alleged Glaxo had funneled bribes totaling $480 million through travel agencies.

Glaxo said it takes all bribery allegations in any country seriously. Last year, it announced an overhaul of its marketing practices, including stopping all payments to doctors to attend conferences or speak about its drugs. Earlier this week, Glaxo cut its full-year earnings outlook after second-quarter profits were hit by weak U.S. sales of its respiratory drugs, currency headwinds and falling sales in China.

Glaxo’s shares are down almost 12% for the year to date.